Christine Matthews - Oct 15, 2021 Form 4 Insider Report for Zosano Pharma Corp (ZSAN)

Role
Chief Financial Officer
Signature
/s/ Steve Lo, as Attorney in Fact for Christine Matthews
Stock symbol
ZSAN
Transactions as of
Oct 15, 2021
Transactions value $
$0
Form type
4
Date filed
10/19/2021, 09:35 PM
Previous filing
Jun 7, 2021
Next filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZSAN Common Stock Award $0 +56.3K +57.23% $0.00 155K Oct 15, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZSAN Stock Option (Right to Buy) Award $0 +113K $0.00 113K Oct 15, 2021 Common Stock 113K $0.63 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the completion of performance vesting.
F2 Includes 56,250 RSUs which are subject to performance vesting.
F3 The shares subject to the stock option vest and become exercisable in accordance with a performance vesting schedule.